Shire clinches $32bn takeover of Baxalta
London-listed pharmaceuticals firm secures cash and stock deal after appeal to Baxalta shareholders Shire expects to save more than $500m…
London-listed pharmaceuticals firm secures cash and stock deal after appeal to Baxalta shareholders Shire expects to save more than $500m…